title: Temporal evolution of epithelial, vascular and interstitial lung injury in an experimental model of idiopathic pulmonary fibrosis induced by butyl-hydroxytoluene.
abstract: This study was undertaken to test whether the structural remodelling of pulmonary parenchyma can be sequentially altered in a model and method that demonstrate the progression of the disease and result in remodelling within the lungs that is typical of idiopathic pulmonary fibrosis. Three groups of mice were studied: (i) animals that received 3-5-di-tert-butyl-4-hydroxytoluene (BHT) and were killed after 2 weeks (early BHT = 9); (ii) animals that received BHT and were killed after 4 weeks (late BHT = 11); (iii) animals that received corn oil solution (control = 10). The mice were placed in a ventilated Plexiglas chamber with a mixture of pure humidified oxygen and compressed air. Lung histological sections underwent haematoxylin-eosin, immunohistochemistry (epithelial, endothelial and immune cells) and specific staining (collagen/elastic fibres) methods for morphometric analysis. When compared with the control group, early BHT and late BHT groups showed significant decrease of type II pneumocytes, lower vascular density in both and higher endothelial activity. CD4 was increased in late BHT compared with early and control groups, while CD8, macrophage and neutrophil cells were more prominent only in early BHT. The collagenous fibre density were significantly higher only in late BHT, whereas elastic fibre content in late BHT was lower than that in control group. We conclude that the BHT experimental model is pathologically very similar to human usual interstitial pneumonia. This feature is important in the identification of animal models of idiopathic pulmonary fibrosis that can accurately reflect the pathogenesis and progression of the human disease.
authors.affiliation: Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil. erparra20003@yahoo.com.br
authors.forename: Edwin Roger
authors.initials: ER
authors.lastname: Parra
authors.forename: Gabriela
authors.initials: G
authors.lastname: Boufelli
authors.forename: Fernanda
authors.initials: F
authors.lastname: Bertanha
authors.forename: Luciana de Paula
authors.initials: Lde P
authors.lastname: Samorano
authors.forename: Armando Costa
authors.initials: AC
authors.lastname: Aguiar
authors.forename: Fernanda Magalhães Arantes
authors.initials: FM
authors.lastname: Costa
authors.forename: Vera Luiza
authors.initials: VL
authors.lastname: Capelozzi
authors.forename: João Valente
authors.initials: JV
authors.lastname: Barbas-Filho
mesh_terms: D000818:Animals; D001808:Blood Vessels / Q000473:pathology; D002084:Butylated Hydroxytoluene; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002450:Cell Communication; D018450:Disease Progression; D004547:Elastic Tissue / Q000473:pathology; D004847:Epithelial Cells / Q000473:pathology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008833:Microcirculation; D009504:Neutrophils / Q000276:immunology; D011650:Pulmonary Alveoli / Q000276:immunology / Q000473:pathology*; D011658:Pulmonary Fibrosis / Q000276:immunology / Q000473:pathology*
chemical_list: D002084:Butylated Hydroxytoluene